SFS Group (SFSN) H2 2023 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2023 earnings summary
1 Nov, 2026Executive summary
Third-party sales CHF 3,090.8m, up 12.6% YoY; organic growth 2.1% and Hoffmann scope effects +14.6% were partly offset by FX impact of -4.1%.
EBIT rose to CHF 358.6m from CHF 330.3m, while EBIT margin eased to 11.7% from 12.1%; EPS was CHF 6.84 vs. CHF 6.95, affected by tax effects.
Results met targets despite a difficult economic environment; Hoffmann integration progressed, and customer-focus organizational changes were initiated.
Financial highlights
FY2023 net sales were CHF 3,073.0m vs. CHF 2,738.7m; EBITDA was CHF 486.0m, 15.8% of sales, vs. CHF 448.1m, 16.4%.
Net income was CHF 268.5m, 8.7% of sales, vs. CHF 270.6m, 9.9%; reported EBIT margin declined 40 bps YoY to 11.7%.
CAPEX increased to CHF 174.0m from CHF 171.0m; operating free cash flow rose to CHF 139.4m from CHF 116.9m.
Outlook and guidance
FY2024 sales development guidance is +3–6% in local currencies, including scope effects; EBIT margin is expected around the prior-year level of 11.7%.
Guidance reflects a challenging geopolitical and economic environment and low visibility; mid-term EBIT margin guidance remains 12–15%.
FY2024 tax rate is expected to decrease toward the prior-year level.
Latest events from SFS Group
- 2026 guidance confirmed: 3–6% sales growth, 12–15% EBIT margin, and strong bond issuance.SFSN
Investor Day 2026 presentation - H1 2026 sales rose 1.3% to CHF 1,559.3m, with 4.0% organic growth and 13.3% EBIT margin.SFSN
H1 2026 - Sales up 0.6% to CHF 3,056.6m, margin improved, dividend stable at CHF 2.50.SFSN
H2 2025 - Adjusted EBIT margin held at 11.0% as CHF 75 million restructuring targets efficiency.SFSN
H1 2025 - SFS drives growth with organizational focus, innovation, and global expansion across key markets.SFSN
Investor Day 2024 Presentation - Sales and profit margins declined, but slight growth and margin improvement are expected in 2024.SFSN
H1 2024 - FY2024 EBIT margin held at 11.6%; 2025 guidance remains cautious amid market uncertainty.SFSN
H2 2024